Optomed’s January-March 2021 interim report to be published on 6 May 2021

Optomed Plc       Press Release      4 May 2021 at 11.30, Helsinki

Optomed’s January-March 2021 interim report to be published on 6 May 2021

Optomed will publish its January-March 2021 interim report on Thursday 6 May 2021 approximately at 9.00 EEST.

A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EEST/10.00 CEST. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EEST at the latest. The participants are requested to register for the call in advance by email to sakari.knuutti@optomed.com.

Please see the call-in numbers below:

FI +358 9 8562 6300

FR +33 1 70 99 53 92

SE +46 8 505 218 52

UK +44 20 3321 5273

US +1 646-838-1719

The conference id is 346 457 303#.

Please note that by dialling in to the conference call, the participant agrees that personal information such as name and company name will be collected.

 

Optomed Plc

Further enquiries
Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com, +358 50 562 4077

 

Optomed in Brief 
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 56 international patents protecting the technology.

Subscribe